ACRP and Devana Solutions Annual Metrics Challenge Study in Analysis Stage

(Washington, DC) – December 17, 2018.   ACRP, a nonprofit that sets standards for clinical research competence has been working in collaboration with Devana Solutions (Devana) and industry-leading Site Networks on a study to analyze research site and network performance data based on workforce qualification.   Said Jim Kremidas, ACRP Executive Director, “In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training and development initiatives and their impact on performance. Since Devana Solutions’ IGNITE for sitessoftware helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on this study.”  The Annual Metrics Challenge Study was launched in April at the ACRP Annual Conference and continues through April 12, 2019 when the next conference opens in Nashville. The results of the study will help gain insights into the impact of clinical trial training and development programs on trial site effectiveness.

Each site or site network participating in the Site Metrics Challenge Study, utilizes Devana Solutions’ IGNITE for sites platformfor more efficient study start-up and analytics on historic and current trial performanceDevana Solutions’ IGNITE for sitesis a cloud-based platform allows sites to gather data in real time, analyze the results and decision against the analytics to drive process improvement and select more of the right trials from therapeutically and operationally-aligned industry Sponsors and CROs.  The first round of site performance metrics data was gathered from participating sites last month and will be collected and analyzed twice more before results of the study are revealed at ACRP Nashville in 2019.

The study is being headlined by key Research Networks –including LMC Manna I Research and IACT Health, with several other sites participating as well.  The study is open to any participating research sites who utilize Devana Solutions IGNITEfor sites technology platform

All participants are excited to be part of this ground-breaking work and shared some thoughts about the challenge.   Said Karri Venn, president of LMC Manna, “For over 20 years we have been on the forefront of clinical trial expertise and support the ARCP’s missing of improving efficiency and effectiveness of clinical trial management.   Given we were using the Devana platform, it was natural to work with the other top site networks to demonstrate each company’s efficiency and effectiveness for the good of the industry.” Added Felicia Irvin, VP Sales and Marketing of IACT Health “We stand behind the ACRP and its rigorous training; we pay for it and reward our employees for getting certified.  With the Devana Solutions overlay, we were in a position to help contribute to the ACRP Annual Metrics Challenge Study.”  Another participant of the challenge, Ashley Meinsenheimer from MedPharmics, saw the value of Devana Solutions’ IGNITE for sitesimmediately given her background in managing large datasets.  Meinsenheimer stated “I was pleased to participate in the ACRP challenge because it provided an opportunity for us to benchmark our site network against the best and it also provided an opportunity to demonstrate the usefulness of the technology to our employees.”

Barry Lake, Co-Founder and CEO of Devana stated “We are delighted to align with ACRP and our partner Site Networks to drive to excellence in clinical research through real time data and analytics.  Site performance data transparency to support the industry-leading trial sites and site networks is our sole focus at Devana.”

Full study results will be shared in the Spring of 2019 during the ACRP Annual Conference.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification.  Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere inthe world. ACRP’s mission is to promote excellence in clinical research.  www.acrpnet.org

Contact:  Jeremy Glunt, media@acrpnet.org(703) 258-3506

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com

 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

Devana Solutions’ IGNITE for sites Technology User Base Continues Rapid Growth; Attesting to the Value of Data Analytics in the Clinical Trials Industry

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.  This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sitestechnology include:

  • Cancer Treatment Centers of America (https://www.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.

 

  • Raleigh Neurology Associates Clinical Research Center(http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.

 

  • University of Washington, Division of Cardiology(https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.

 

  • Javara Research(https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.

 

  • Elias Research Associates(https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

IGNITE for sites Growth Demonstrates Value of Data Analytics in Clinical Trials

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.   This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sites technology include:

  • Cancer Treatment Centers of America (https://beta.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.
  • Raleigh Neurology Associates Clinical Research Center (http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.
  • University of Washington, Division of Cardiology (https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.
  • Javara Research (https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.
  • Elias Research Associates (https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.About Devana Solutions, LLCDevana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com   

    Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151